BridgeMD
New treatment option for Colorectal Cancer
Official title An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
ClinicalTrials.gov ID: NCT07033026
What this study is testing
What is NGM120 Q4W?
NGM120 Q4W is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for colorectal cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Documented active diagnosis of colorectal cancer.
- Cachexia defined by Fearon criteria of weight loss.
- Signed informed consent.
You likely can't join if
- Current active reversible causes of decreased food intake.
- Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.
- Have cachexia caused by other reasons.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
- Santa Rosa, California, United States
- Margate, Florida, United States
- Baltimore, Maryland, United States
- New York, New York, United States
- Toledo, Ohio, United States
- Youngstown, Ohio, United States
- Dallas, Texas, United States
- Kingwood, Texas, United States
- Laredo, Texas, United States
- Richmond, Virginia, United States
- Appleton, Wisconsin, United States
- Tbilisi, Georgia
- Goyang, South Korea
- Incheon, South Korea
- Seoul, South Korea
- Suwon, South Korea
- Taichung, Taiwan
- Taipei, Taiwan
- Taoyuan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States; Santa Rosa, California, United States; Margate, Florida, United States; Baltimore, Maryland, United States; New York, New York, United States; Toledo, Ohio, United States and 14 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.